Genetics and imaging of hepatocellular adenomas: 2011 update.

Hepatocellular adenomas are benign liver neoplasms with specific but varied histopathologic findings and tumor biology. The results from recent studies of the pathologic and genetic basis of hepatocellular adenomas provide important insights into the pathogenesis and molecular changes, as well as the putative oncologic pathways used by diverse adenoma subtypes. On the basis of the genetic and pathologic features, hepatocellular adenomas are categorized into three distinct subtypes: (a) inflammatory hepatocellular adenomas, (b) hepatocyte nuclear factor 1 α-mutated hepatocellular adenomas, and (c) β-catenin-mutated hepatocellular adenomas. Different subtypes show variable clinical behavior, imaging findings, and natural history, and thus the options for treatment and surveillance may vary. Cross-sectional imaging plays an important role in the diagnosis, subtype characterization, identification of complications, and surveillance of hepatocellular adenomas. New schemas for genotype-phenotype classification of hepatic adenomas, as well as management triage of patients with specific subtypes of adenomas, are being proposed in an attempt to improve clinical outcomes.

[1]  M. Ronot,et al.  Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification , 2011, Hepatology.

[2]  V. Paradis,et al.  Changing trends in malignant transformation of hepatocellular adenoma , 2010, Gut.

[3]  J. Zucman‐Rossi,et al.  Subtype Classification of Hepatocellular Adenoma , 2010, Digestive Surgery.

[4]  J. Zucman‐Rossi,et al.  561 CONTRAST-ENHANCED ULTRA SONOGRAPHY TO IDENTIFY THE TWO MAJOR SUBTYPES OF HEPATOCELLULAR ADENOMA , 2010 .

[5]  O. Farges,et al.  Malignant Transformation of Liver Adenoma: An Analysis of the Literature , 2010, Digestive Surgery.

[6]  V. Paradis,et al.  A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. , 2009, Gastroenterology.

[7]  J. Ijzermans,et al.  Hepatocellular adenoma: cost-effectiveness of different treatment strategies. , 2009, Radiology.

[8]  J. Zucman‐Rossi,et al.  Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience , 2009, Hepatology.

[9]  C. Trautwein,et al.  Frequent in‐frame somatic deletions activate gp130 in inflammatory hepatocellular tumors , 2009, Hepatology.

[10]  S. Imbeaud,et al.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours , 2009, Nature.

[11]  Paulette Bioulac-Sage,et al.  Hepatocellular adenomas , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[12]  Yutaka Takigawa,et al.  Wnt signaling in liver cancer. , 2008, Current drug targets.

[13]  H. Rhim,et al.  Radiofrequency ablation of hepatic tumors: Lessons learned from 3000 procedures , 2008, Journal of gastroenterology and hepatology.

[14]  J. Zucman‐Rossi,et al.  Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification , 2008, Hepatology.

[15]  J. Zucman‐Rossi,et al.  Hepatocellular adenoma: what is new in 2008 , 2008, Hepatology international.

[16]  D. Gouma,et al.  Liver adenomatosis: re‐evaluation of aetiology and management , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[17]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[18]  M. Ronot,et al.  Telangiectatic adenoma: An entity associated with increased body mass index and inflammation , 2007, Hepatology.

[19]  J. Zucman‐Rossi,et al.  Genotype phenotype classification of hepatocellular adenoma. , 2007, World journal of gastroenterology.

[20]  C. Auffray,et al.  HNF1α Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation* , 2007, Journal of Biological Chemistry.

[21]  S. Monga,et al.  WNT/β‐catenin signaling in liver health and disease , 2007 .

[22]  V. Paradis,et al.  Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. , 2006, Radiology.

[23]  V. Huurman,et al.  Necrosis of a large hepatic tumor after hemorrhage and subsequent selective arterial embolization. , 2006, World journal of gastroenterology.

[24]  D. Gouma,et al.  Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[25]  J. Zucman‐Rossi,et al.  Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.

[26]  J. Zucman‐Rossi,et al.  Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. , 2005, Gastroenterology.

[27]  J. Charboneau,et al.  Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. , 2005, AJR. American journal of roentgenology.

[28]  William D Middleton,et al.  Fat-containing lesions of the liver: radiologic-pathologic correlation. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[29]  J. Zucman‐Rossi,et al.  Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. , 2003, Gastroenterology.

[30]  J. Van Damme,et al.  The CC chemokine CCL20 and its receptor CCR6. , 2003, Cytokine & growth factor reviews.

[31]  M. Buendia Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. , 2002, Medical and pediatric oncology.

[32]  Y. Jeng,et al.  p53 gene and Wnt signaling in benign neoplasms: β‐catenin mutations in hepatic adenoma but not in focal nodular hyperplasia , 2002, Hepatology.

[33]  J. Zucman‐Rossi,et al.  Bi-allelic inactivation of TCF1 in hepatic adenomas , 2002, Nature Genetics.

[34]  T. Ichikawa,et al.  Hepatic adenomas: imaging and pathologic findings. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[35]  T. Ichikawa,et al.  Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. , 2000, Radiology.

[36]  J. Liehr,et al.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.

[37]  T. Ichikawa,et al.  Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. , 2000, Radiology.

[38]  G. Gores,et al.  Management of liver adenomatosis: results with a conservative surgical approach. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[39]  C. Degott,et al.  Liver adenomatosis. An entity distinct from liver adenoma? , 1985, Gastroenterology.

[40]  B. Henderson,et al.  Liver-cell adenomas associated with use of oral contraceptives. , 1976, The New England journal of medicine.

[41]  Wesley O C Greaves,et al.  Hepatic adenomatosis. , 2008, Archives of pathology & laboratory medicine.

[42]  S. Monga,et al.  WNT/beta-catenin signaling in liver health and disease. , 2007, Hepatology.

[43]  M. Wolverson,et al.  Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report. , 2005, Seminars in liver disease.

[44]  S. Ellard Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. , 2000, Human mutation.

[45]  J. Grosgeorge,et al.  Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11. , 1995, Cytogenetics and cell genetics.